Vinod Pullarkat
0000-0001-9129-3424
8 papers found
Refreshing results…
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1‐ or IDH2‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia
Optimizing CAR‐T cell therapy in adults with B‐cell acute lymphoblastic leukemia
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
Adoptive transfer of functional SARS‐COV ‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients
Outcome of secondary Acute Myeloid Leukemia treated with Hypomethylating agent plus Venetoclax ( HMA‐Ven ) or Liposomal Daunorubicin‐Cytarabine ( CPX ‐351)
Missing publications? Search for publications with a matching author name.